OTCMKTS:SPHS

Sophiris Bio - SPHS Stock Forecast, Price & News

Add

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: $4,000.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Institutional Ownership

Headlines

SEC Filings

Short Interest

About Sophiris Bio (OTCMKTS:SPHS) Stock

Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA.

Receive SPHS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sophiris Bio and its competitors with MarketBeat's FREE daily newsletter.

SPHS Stock News Headlines

March 20, 2023 | finance.yahoo.com

Sophiris Bio Inc. Registered Sh (BFF1.SG)

January 25, 2023 | msn.com

SPHS Indoor Track Wins Girls Blue Division at GMC Championships

March 26, 2023 | Investor Place Media (Ad)

Biden To Unleash "Choke Point" Operation On America?

Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.

January 17, 2023 | msn.com

SPHS Weekly Sports Recap: All Sports Notch Big Wins

October 24, 2020 | nasdaq.com

Sophiris Bio Inc (SPHS)

August 19, 2020 | ca.finance.yahoo.com

Sophiris Bio, Inc. (SPHS)

May 18, 2020 | finance.yahoo.com

Sophiris Bio To Shut Down Operations

April 25, 2020 | www.barrons.com

Sophiris Bio Inc.

March 26, 2023 | Weiss Ratings (Ad)

Urgent Warning

This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …

March 10, 2020 | seekingalpha.com

Sophiris to delist; shares plummet 42% after hours

March 10, 2020 | finance.yahoo.com

Sophiris Bio Announces Nasdaq Delisting

February 22, 2020 | finance.yahoo.com

SPHS Feb 2020 2.500 call

November 18, 2019 | finance.yahoo.com

SPHS: Single Phase 3 Clinical Trial Planned for Topsalysin in Localized Prostate Cancer…

November 13, 2019 | seekingalpha.com

Sophiris Bio files for equity offering

November 7, 2019 | finance.yahoo.com

Sophiris Bio Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights

October 21, 2019 | finance.yahoo.com

Sophiris Bio Receives Positive Feedback from FDA Regarding Phase 3 Localized Prostate Cancer Clinical Trial Design

August 30, 2019 | finance.yahoo.com

Sophiris Bio Announces Completion of $4.0 Million Registered Direct Offering

August 30, 2019 | finance.yahoo.com

Sophiris Bio to Present at the H.C. Wainwright 21st Annual Global Investment Conference

August 27, 2019 | finance.yahoo.com

SPHS: Awaiting Feedback from FDA on Phase 3 Plan for Topsalysin in Prostate Cancer…

August 27, 2019 | seekingalpha.com

Sophiris Bio secures $4M capital raise

August 9, 2019 | seekingalpha.com

Sophiris Bio EPS beats by $0.04

June 20, 2019 | finance.yahoo.com

SPHS: Details of Phase 3 Prostate Cancer Trial Based on Positive EMA Feedback…

June 19, 2019 | finance.yahoo.com

Sophiris Bio Receives Positive Feedback from European Medicines Agency Regarding Phase 3 Localized Prostate Cancer Clinical Trial Design

June 14, 2019 | finance.yahoo.com

Some Sophiris Bio (FRA:BFF1) Shareholders Have Taken A Painful 79% Share Price Drop

May 14, 2019 | finance.yahoo.com

SPHS: EMA Guidance on Phase 3 Clinical Trial for Topsalysin Expected in 2Q19…

May 9, 2019 | finance.yahoo.com

Sophiris Bio Reports First Quarter 2019 Financial Results

April 2, 2019 | finance.yahoo.com

Sophiris Bio to Present at Two Upcoming Investor Conferences

See More Headlines

Receive SPHS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sophiris Bio and its competitors with MarketBeat's FREE daily newsletter.

SPHS Company Calendar

Last Earnings: 5/09/2019
Today: 3/26/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:SPHS
CUSIP: N/A
CIK: 1563855
Web: www.sophirisbio.com
Phone: (858) 777-1760
Fax: N/A
Employees: 2,018
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 35,550,000
Free Float: N/A
Market Cap: $4,000.00
Optionable: Not Optionable
Beta: 1.94

Key Executives

Randall E. Woods
President & Chief Executive Officer

Peter T. Slover
Chief Financial & Accounting Officer

Key Competitors

View All Competitors

SPHS Stock - Frequently Asked Questions

How were Sophiris Bio's earnings last quarter?: Sophiris Bio, Inc. (OTCMKTS:SPHS) announced its quarterly earnings results on Thursday, May, 9th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.02.
What is Sophiris Bio's stock symbol?: Sophiris Bio trades on the OTCMKTS under the ticker symbol "SPHS."

How do I buy shares of Sophiris Bio?: Shares of SPHS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
How much money does Sophiris Bio make?: Sophiris Bio (OTCMKTS:SPHS) has a market capitalization of $0.00.
How many employees does Sophiris Bio have?: The company employs 2,018 workers across the globe.
How can I contact Sophiris Bio?: Sophiris Bio's mailing address is 1258 PROSPECT STREET, LA JOLLA CA, 92037. The official website for the company is www.sophirisbio.com. The company can be reached via phone at (858) 777-1760 or via email at cdavis@lifesciadvisors.com.

This page (OTCMKTS:SPHS) was last updated on 3/26/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial